Exact Mass: 427.2484
Exact Mass Matches: 427.2484
Found 133 metabolites which its exact mass value is equals to given mass value 427.2484
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ranolazine
Ranolazine is only found in individuals that have used or taken this drug. It is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina. [Wikipedia]The mechanism of action of ranolazine is unknown. It does not increase the rate-pressure product, a measure of myocardial work, at maximal exercise. In vitro studies suggest that ranolazine is a P-gp inhibitor. Ranolazine is believed to have its effects via altering the trans-cellular late sodium current. It is by altering the intracellular sodium level that ranolazine affects the sodium-dependent calcium channels during myocardial ischemia. Thus, ranolazine indirectly prevents the calcium overload that causes cardiac ischemia. C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Valyl-prolyl-glycyl-valyl-glycine
RANOLAZINE
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Ile Pro Gln
Ala Ile Gln Pro
Ala Leu Pro Gln
Ala Leu Gln Pro
Ala Pro Ile Gln
Ala Pro Leu Gln
Ala Pro Gln Ile
Ala Pro Gln Leu
Ala Gln Ile Pro
Ala Gln Leu Pro
Ala Gln Pro Ile
Ala Gln Pro Leu
Gly Pro Arg Val
Gly Pro Val Arg
Gly Arg Pro Val
Gly Arg Val Pro
Gly Val Pro Arg
Gly Val Arg Pro
Ile Ala Pro Gln
Ile Ala Gln Pro
Ile Pro Ala Gln
Ile Pro Gln Ala
Ile Gln Ala Pro
Ile Gln Pro Ala
Lys Pro Pro Ser
Lys Pro Ser Pro
Lys Ser Pro Pro
Leu Ala Pro Gln
Leu Ala Gln Pro
Leu Pro Ala Gln
Leu Pro Gln Ala
Leu Gln Ala Pro
Leu Gln Pro Ala
Asn Pro Val Val
Asn Val Pro Val
Asn Val Val Pro
Pro Ala Ile Gln
Pro Ala Leu Gln
Pro Ala Gln Ile
Pro Ala Gln Leu
Pro Gly Arg Val
Pro Gly Val Arg
Pro Ile Ala Gln
Pro Ile Gln Ala
Pro Lys Pro Ser
Pro Lys Ser Pro
Pro Leu Ala Gln
Pro Leu Gln Ala
Pro Asn Val Val
Pro Pro Lys Ser
Pro Pro Ser Lys
Pro Gln Ala Ile
Pro Gln Ala Leu
Pro Gln Ile Ala
Pro Gln Leu Ala
Pro Arg Gly Val
Pro Arg Val Gly
Pro Ser Lys Pro
Pro Ser Pro Lys
Pro Val Gly Arg
Pro Val Asn Val
Pro Val Arg Gly
Pro Val Val Asn
Gln Ala Ile Pro
Gln Ala Leu Pro
Gln Ala Pro Ile
Gln Ala Pro Leu
Gln Ile Ala Pro
Gln Ile Pro Ala
Gln Leu Ala Pro
Gln Leu Pro Ala
Gln Pro Ala Ile
Gln Pro Ala Leu
Gln Pro Ile Ala
Gln Pro Leu Ala
Arg Gly Pro Val
Arg Gly Val Pro
Arg Pro Gly Val
Arg Pro Val Gly
Arg Val Gly Pro
Arg Val Pro Gly
Ser Lys Pro Pro
Ser Pro Lys Pro
Ser Pro Pro Lys
Val Gly Pro Arg
Val Gly Arg Pro
Val Asn Pro Val
Val Asn Val Pro
Val Pro Gly Arg
Val Pro Asn Val
Val Pro Arg Gly
Val Pro Val Asn
Val Arg Gly Pro
Val Arg Pro Gly
Val Val Asn Pro
Val Val Pro Asn
20-hydroxy N-Arachidonoyl Taurine
bis[tris(dimethylamino)-λ5-phosphanylidene]azanium,tetrafluoroborate
Ivaltinostat
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(2S,3R)-2-[[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid
4-[(4-Cyclohexyl-1-piperazinyl)-oxomethyl]-2-ethyl-6,7-dimethoxy-1-isoquinolinone
N-(1-cyclohexyl-3-hydroxy-3,4-diphenylbutyl)benzamide
N-Benzylidene-1-amino(hepta)ethyleneglycol monomethyl ether
(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
14-(Methoxycarbonyl)-4,4,8alpha,12,16-pentamethyl-3,17-dioxo-5beta,9beta,10alpha,13alpha-androsta-11,15-dien-15-olate
(1R,9S,10S,11S)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
andrastin D(1-)
An enolate anion resulting from the deprotonation of the enol of andrastin D.Major species at pH 7.3. Published in http://dx.doi.org/10.1016/j.tet.2013.07.029